Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Revelation Biosciences Inc

REVB
Current price
0.85 USD -0.019 USD (-2.19%)
Last closed 0.87 USD
ISIN US76135L1017
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 3 186 834 USD
Yield for 12 month -95.34 %
1Y
3Y
5Y
10Y
15Y
REVB
21.11.2021 - 28.11.2021

Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-SSI, a potential therapy for the prevention and treatment of surgical sit infection; GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was founded in 2020 and is based in San Diego, California. Address: 4660 La Jolla Village Drive, San Diego, CA, United States, 92122

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

14.45 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-25 049 USD

Last Year

-40 008 USD

Current Quarter

-7 220 USD

Last Quarter

-6 262 USD

Key Figures REVB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -9 502 316 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -42.07 %
PEG Ratio
Return On Equity TTM -253.32 %
Wall Street Target Price 14.45 USD
Revenue TTM
Book Value 0.69 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM 90 905 000 USD
Earnings per share -33.18 USD
Diluted Eps TTM -33.18 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics REVB

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History REVB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:30
Payout Ratio
Last Split Date 25.01.2024
Dividend Date

Stock Valuation REVB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 7.7942
Enterprise Value Revenue
Price Sales TTM 2.8821
Enterprise Value EBITDA -1.0183
Price Book MRQ 2.7121

Financials REVB

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators REVB

For 52 weeks

0.7 USD 23.7 USD
50 Day MA 0.89 USD
Shares Short Prior Month 56 568
200 Day MA 2.25 USD
Short Ratio 0.13
Shares Short 22 746
Short Percent 0.61 %